John Libbey Eurotext

European Journal of Dermatology

MENU

Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study Volume 27, numéro 4, July-August 2017

Illustrations

  • Figure 1

Tableaux

Auteurs
Department of Dermatology,
IRCCS AOU San Martino IST,
Largo R. Benzi,
10, 16132 Genoa,
Italy
* Reprints
a Authors contributed equally

Background

Nicotinamide is the precursor of nicotinamide adenine dinucleotide (NAD+), an essential cofactor for adenosine triphosphate (ATP) production. It has recently been reported to be effective in reducing the rates of new non-melanoma skin cancers (NMSCs) and actinic keratosis (AKs).